ClinVar Miner

Submissions for variant NM_002618.4(PEX13):c.121A>G (p.Thr41Ala)

dbSNP: rs757604504
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001877926 SCV002155210 uncertain significance Peroxisome biogenesis disorder 11A (Zellweger) 2021-04-17 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with PEX13-related conditions. This variant is present in population databases (rs757604504, ExAC 0.002%). This sequence change replaces threonine with alanine at codon 41 of the PEX13 protein (p.Thr41Ala). The threonine residue is moderately conserved and there is a small physicochemical difference between threonine and alanine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.